NeuroMetrix Stock (NASDAQ: NURO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 12.000 / 49.249K |
Day Range | - - - |
52 Wk Range | 0.451 - 11.822 |
Market Cap | $9.357M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 0.58% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NeuroMetrix (NASDAQ: NURO) through any online brokerage.
Other companies in NeuroMetrix’s space includes: Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO), Talis Biomedical (NASDAQ:TLIS) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for NeuroMetrix (NASDAQ: NURO) was reported by Rodman & Renshaw on Tuesday, June 28, 2016. The analyst firm set a price target for 4.50 expecting NURO to fall to within 12 months (a possible -4.46% downside). 0 analyst firms have reported ratings in the last year.
The stock price for NeuroMetrix (NASDAQ: NURO) is $4.71 last updated April 23, 2024 at 8:16 AM EDT.
There are no upcoming dividends for NeuroMetrix.
NeuroMetrix’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for NeuroMetrix.
NeuroMetrix is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.